MAR 06, 2015 7:45 AM PST

Gorillas are the source of 50% of HIV strains, study says

WRITTEN BY: Robert Woodard
Western lowland gorilla
There are 4 known groups of HIV strains that affect humans. Two of them originated in western lowland gorillas in Africa, according to a report by researchers from the University of Pennsylvania published in the March 2 edition of the Proceedings of the National Academy of Sciences.

The international research team screened fecal samples from eastern lowland gorillas, western lowland gorillas, and mountain gorillas in Cameroon, Gabon, Uganda, and the Democratic Republic of Congo for signs of simian immunodeficiency virus (SIV) infection.

The 4 known groups of HIV-1 strains are referred to as M, N, O and P. Other studies have found that groups M and N originated in chimpanzee in southern Cameroon, but the origin of the O and P strains has been uncertain. Now the Penn team has found that the O and P groups also originated in Cameroon, but in western lowland gorillas.

All 4 groups of HIV strains can infect humans. The group M strain was responsible for the AIDS epidemic that killed millions of people worldwide. The group O strain has also infected a large number of people in Africa (approximately 100,000). So far, the other two groups (N and P) have only been identified in a handful of individuals in Cameroon.

Dr. Beatrice Hahn, a professor of medicine and microbiology at Penn and a member of the research team explained that viral sequencing revealed a high degree of genetic diversity among the different gorilla samples and that two lineages of SIV were especially close to HIV groups O and P, indicating that those groups originated in western lowland gorillas.

This study and others that the team has conducted have made it clear that both chimpanzees and gorillas harbor viruses that are capable of crossing the species barrier to humans and have the potential to cause major disease outbreaks. The results of these studies are critical for understanding origins of emerging disease and gauging the risk of future human infection.

Source: www.redorbit.com
About the Author
You May Also Like
OCT 12, 2021
Health & Medicine
Atopic Dermatitis: A Harbinger of Autoimmune Diseases?
OCT 12, 2021
Atopic Dermatitis: A Harbinger of Autoimmune Diseases?
New research published in Allergy, Asthma & Clinical Immunology found an increased risk of autoimmune disease develo ...
NOV 04, 2021
Cancer
Giving the Immune System a Kickstart to Improve Immunotherapy Efficacy
NOV 04, 2021
Giving the Immune System a Kickstart to Improve Immunotherapy Efficacy
Despite the incremental success immune checkpoint inhibitors (ICI) have attributed to the cancer treatment landscape rec ...
NOV 30, 2021
Immunology
Sweet Escape: A Sugar Molecule Helps HIV Remain Incognito
NOV 30, 2021
Sweet Escape: A Sugar Molecule Helps HIV Remain Incognito
HIV is a master of disguise. Once the virus enters the body, it has a number of sophisticated mechanisms through which i ...
DEC 23, 2021
Immunology
Hitting the Anti-inflammatory Bullseye to Treat IBD
DEC 23, 2021
Hitting the Anti-inflammatory Bullseye to Treat IBD
Fifty percent—that’s the percentage of patients with inflammatory bowel disease (IBD) who experience long-te ...
DEC 30, 2021
Clinical & Molecular DX
Treating Rheumatoid Arthritis: No More Trial and Error?
DEC 30, 2021
Treating Rheumatoid Arthritis: No More Trial and Error?
  Treating rheumatoid arthritis can be like throwing darts—doctors don’t always hit the bullseye. Trial ...
JAN 13, 2022
Immunology
Gene Unveiled as Missing Link in Antibody Development
JAN 13, 2022
Gene Unveiled as Missing Link in Antibody Development
  Antibodies are a core part of the immune system's pathogen-fighting arsenal, defending the body against bacte ...
Loading Comments...